Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 8
2004 4
2005 7
2006 7
2007 9
2008 6
2009 10
2010 9
2011 12
2012 8
2013 5
2014 11
2015 13
2016 8
2017 5
2018 10
2019 7
2020 17
2021 16
2022 12
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Indoor Inactivation of SARS-CoV-2 Virus by Liquid Hyperoxygen.
Barco G, Khalid Z, Pulliero A, Angelinetta C, Prati U, Izzotti A. Barco G, et al. Among authors: izzotti a. Pathogens. 2024 Mar 11;13(3):244. doi: 10.3390/pathogens13030244. Pathogens. 2024. PMID: 38535587 Free PMC article.
SARS-CoV-2 presence in recreational seawater and evaluation of intestine permeability: experimental evidence of low impact on public health.
Norese C, Nicosia E, Cortese K, Gentili V, Rizzo R, Rizzo S, Grasselli E, De Negri Atanasio G, Gagliani MC, Tiso M, Zinni M, Pulliero A, Izzotti A. Norese C, et al. Among authors: izzotti a. Front Public Health. 2024 Mar 4;12:1326453. doi: 10.3389/fpubh.2024.1326453. eCollection 2024. Front Public Health. 2024. PMID: 38500723 Free PMC article.
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology.
Ben Toumia I, Bachetti T, Chekir-Ghedira L, Profumo A, Ponassi M, Di Domizio A, Izzotti A, Sciacca S, Puglisi C, Forte S, Giuffrida R, Colarossi C, Milardi D, Grasso G, Lanza V, Fiordoro S, Drago G, Tkachenko K, Cardinali B, Romano P, Iervasi E, Vargas GC, Barboro P, Kohnke FH, Rosano C. Ben Toumia I, et al. Among authors: izzotti a. Front Pharmacol. 2024 Jan 3;14:1258108. doi: 10.3389/fphar.2023.1258108. eCollection 2023. Front Pharmacol. 2024. PMID: 38235113 Free PMC article.
A review of phase II and III drugs for the treatment and management of endometriosis.
Perrone U, Evangelisti G, Laganà AS, Bogliolo S, Ceccaroni M, Izzotti A, Gustavino C, Ferrero S, Barra F. Perrone U, et al. Among authors: izzotti a. Expert Opin Emerg Drugs. 2023 Dec;28(4):333-351. doi: 10.1080/14728214.2023.2296080. Epub 2023 Dec 26. Expert Opin Emerg Drugs. 2023. PMID: 38099328 Review.
Current Medical Therapy for Adenomyosis: From Bench to Bedside.
Etrusco A, Barra F, Chiantera V, Ferrero S, Bogliolo S, Evangelisti G, Oral E, Pastore M, Izzotti A, Venezia R, Ceccaroni M, Laganà AS. Etrusco A, et al. Among authors: izzotti a. Drugs. 2023 Nov;83(17):1595-1611. doi: 10.1007/s40265-023-01957-7. Epub 2023 Oct 14. Drugs. 2023. PMID: 37837497 Free PMC article. Review.
186 results